“Living Drug Factory” May be the Future Treatment for Chronic Diseases that Require Hormone Injections like Diabetes
source: pixabay.com

“Living Drug Factory” May be the Future Treatment for Chronic Diseases that Require Hormone Injections like Diabetes

  A person with diabetes is not able to properly make or use insulin well. Advancements in science are now seriously looking at updating and perfecting ways to help people…

Continue Reading “Living Drug Factory” May be the Future Treatment for Chronic Diseases that Require Hormone Injections like Diabetes
New Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response
Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

New Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response

  According to new research from the Journal of Infectious Diseases, a new protein epitope has been discovered while testing the immune response of people with Kawasaki Disease. Kawasaki Disease, also…

Continue Reading New Research Identifies Protein Epitope Targeted in Kawasaki Disease Immune Response
Coronavirus: Could Medical Rationing Put the Chronically Ill/Disabled in Danger?
source: pixabay.com

Coronavirus: Could Medical Rationing Put the Chronically Ill/Disabled in Danger?

In a story written for The Washington Post, Jessica Slice writes about a frightful predicament for patients with chronic illnesses that cause disability. Jessica lives with dysautonomia and hypermobile Ehlers-Danlos…

Continue Reading Coronavirus: Could Medical Rationing Put the Chronically Ill/Disabled in Danger?
FDA Approves a Treatment for Neurofibromatosis Type 1 for the First Time Ever
source: pixabay.com

FDA Approves a Treatment for Neurofibromatosis Type 1 for the First Time Ever

A press release from the US Food and Drug Administration (FDA) recently announced the approval of the drug selumetinib (marketed as Koselugo) for the treatment of patients aged two years…

Continue Reading FDA Approves a Treatment for Neurofibromatosis Type 1 for the First Time Ever
Sex and Age Discrimination Could be Impeding Scientific Research for Conditions Like Cushing Syndrome
source: pixabay.com

Sex and Age Discrimination Could be Impeding Scientific Research for Conditions Like Cushing Syndrome

NICHD The NICHD is the The Eunice Kennedy Shriver National Institute of Child Health and Human Development, one of the National Institutes of Health (NIH). It is the center for…

Continue Reading Sex and Age Discrimination Could be Impeding Scientific Research for Conditions Like Cushing Syndrome
Study: Felty’s Syndrome Presents Differently in Pediatric Patients
source: pixabay.com

Study: Felty’s Syndrome Presents Differently in Pediatric Patients

According to a study published in BMC Pediatrics, the rare disease known as Felty's syndrome is primarily known to affects adults between the ages of 50 and 70, but on very rare…

Continue Reading Study: Felty’s Syndrome Presents Differently in Pediatric Patients
Handling Rare Diseases and COVID-19: National Organization for Rare Disorders Reminds You to Stay Strong
source: pixabay.com

Handling Rare Diseases and COVID-19: National Organization for Rare Disorders Reminds You to Stay Strong

  If you're worried or anxious because of COVID-19, you're not alone. If wondering about the intersection of rare diseases and COVID-19 only increases that anxiety, well, we're with you…

Continue Reading Handling Rare Diseases and COVID-19: National Organization for Rare Disorders Reminds You to Stay Strong
Planting Love Around the World: A Young Patient with Neurofibromatosis Works to Reduce COVID-19 Anxiety
source: pixabay.com

Planting Love Around the World: A Young Patient with Neurofibromatosis Works to Reduce COVID-19 Anxiety

  According to a story from Wexford People, 8-year-old Mia-Lily Ruttle wants to spread some hope to people around the globe. The girl, who has neurofibromatosis, was upset by the impact…

Continue Reading Planting Love Around the World: A Young Patient with Neurofibromatosis Works to Reduce COVID-19 Anxiety
Rivaroxaban Lowers Risk of Venous Thromboembolism for Orthopedic Surgeries as Compared to Heparin
source: pixabay.com

Rivaroxaban Lowers Risk of Venous Thromboembolism for Orthopedic Surgeries as Compared to Heparin

  According to a news release from the American College of Cardiology, rivaroxaban is more effective than enoxaprin (heparin) in preventing blood clots or low platelet counts in patients after…

Continue Reading Rivaroxaban Lowers Risk of Venous Thromboembolism for Orthopedic Surgeries as Compared to Heparin
BIO-X® Grant Given to Ilya Pharma to Develop Gene Therapy Solutions for Patients with Inflammatory Bowel Disease
source: pixabay.com

BIO-X® Grant Given to Ilya Pharma to Develop Gene Therapy Solutions for Patients with Inflammatory Bowel Disease

  According to Microbiome Times, Ilya Pharma has received a BIO-X® grant to study gene therapy for patients with inflammatory bowel disease. Their chemokine-based gene therapy drug candidates seek to…

Continue Reading BIO-X® Grant Given to Ilya Pharma to Develop Gene Therapy Solutions for Patients with Inflammatory Bowel Disease
FDA Accepts NDA for a Potential Pulmonary Arterial Hypertension Treatment
source: pixabay.com

FDA Accepts NDA for a Potential Pulmonary Arterial Hypertension Treatment

According to a story from globenewswire.com, the biopharmaceutical company Liquidia Technologies, Inc. just announced that the company's New Drug Application (NDA) has been officially accepted by the US Food and…

Continue Reading FDA Accepts NDA for a Potential Pulmonary Arterial Hypertension Treatment